Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation

Disseminated intravascular coagulation (DIC) has been recognized as a deadly complication in sepsis, and its early recognition followed by appropriate management of the underlying infection are the current management strategies. The activation of coagulation, inflammation, and other pathways are fun...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Seminars in thrombosis and hemostasis Ročník 46; číslo 1; s. 89
Hlavní autoři: Iba, Toshiaki, Levi, Marcel, Levy, Jerrold H
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States 01.02.2020
ISSN:1098-9064, 1098-9064
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Disseminated intravascular coagulation (DIC) has been recognized as a deadly complication in sepsis, and its early recognition followed by appropriate management of the underlying infection are the current management strategies. The activation of coagulation, inflammation, and other pathways are fundamental host responses against infection but also produce injury to the host. Recent advances have helped define the critical roles of thrombus formation in overcoming infection. In addition to activation of coagulation induced by pathogens, other important pathways including damage-associated molecular patterns, neutrophil extracellular traps, extracellular vesicles, and glycocalyx damage are involved in the pathogenesis of sepsis-induced DIC. The hallmark of DIC is thrombosis in the microvasculature; however, sepsis-induced DIC is a laboratory diagnosis based on coagulation test results and clinical setting. Although simplified criteria were recently introduced, DIC should be distinguished from other similar conditions such as thrombotic microangiopathy and heparin-induced thrombocytopenia. In DIC, treating the underlying cause is crucial, and additional adjunct therapies including antithrombin, thrombomodulin, and heparins may have potential benefit, but evidence supporting their use in terms of improvement of clinically relevant outcomes continues to be debated. In this review, we introduce recent findings regarding the pathophysiology, diagnosis, and treatment of sepsis-induced DIC. In addition, we also discuss future potential therapeutic approaches regarding this complex, life-threatening complication.
AbstractList Disseminated intravascular coagulation (DIC) has been recognized as a deadly complication in sepsis, and its early recognition followed by appropriate management of the underlying infection are the current management strategies. The activation of coagulation, inflammation, and other pathways are fundamental host responses against infection but also produce injury to the host. Recent advances have helped define the critical roles of thrombus formation in overcoming infection. In addition to activation of coagulation induced by pathogens, other important pathways including damage-associated molecular patterns, neutrophil extracellular traps, extracellular vesicles, and glycocalyx damage are involved in the pathogenesis of sepsis-induced DIC. The hallmark of DIC is thrombosis in the microvasculature; however, sepsis-induced DIC is a laboratory diagnosis based on coagulation test results and clinical setting. Although simplified criteria were recently introduced, DIC should be distinguished from other similar conditions such as thrombotic microangiopathy and heparin-induced thrombocytopenia. In DIC, treating the underlying cause is crucial, and additional adjunct therapies including antithrombin, thrombomodulin, and heparins may have potential benefit, but evidence supporting their use in terms of improvement of clinically relevant outcomes continues to be debated. In this review, we introduce recent findings regarding the pathophysiology, diagnosis, and treatment of sepsis-induced DIC. In addition, we also discuss future potential therapeutic approaches regarding this complex, life-threatening complication.Disseminated intravascular coagulation (DIC) has been recognized as a deadly complication in sepsis, and its early recognition followed by appropriate management of the underlying infection are the current management strategies. The activation of coagulation, inflammation, and other pathways are fundamental host responses against infection but also produce injury to the host. Recent advances have helped define the critical roles of thrombus formation in overcoming infection. In addition to activation of coagulation induced by pathogens, other important pathways including damage-associated molecular patterns, neutrophil extracellular traps, extracellular vesicles, and glycocalyx damage are involved in the pathogenesis of sepsis-induced DIC. The hallmark of DIC is thrombosis in the microvasculature; however, sepsis-induced DIC is a laboratory diagnosis based on coagulation test results and clinical setting. Although simplified criteria were recently introduced, DIC should be distinguished from other similar conditions such as thrombotic microangiopathy and heparin-induced thrombocytopenia. In DIC, treating the underlying cause is crucial, and additional adjunct therapies including antithrombin, thrombomodulin, and heparins may have potential benefit, but evidence supporting their use in terms of improvement of clinically relevant outcomes continues to be debated. In this review, we introduce recent findings regarding the pathophysiology, diagnosis, and treatment of sepsis-induced DIC. In addition, we also discuss future potential therapeutic approaches regarding this complex, life-threatening complication.
Disseminated intravascular coagulation (DIC) has been recognized as a deadly complication in sepsis, and its early recognition followed by appropriate management of the underlying infection are the current management strategies. The activation of coagulation, inflammation, and other pathways are fundamental host responses against infection but also produce injury to the host. Recent advances have helped define the critical roles of thrombus formation in overcoming infection. In addition to activation of coagulation induced by pathogens, other important pathways including damage-associated molecular patterns, neutrophil extracellular traps, extracellular vesicles, and glycocalyx damage are involved in the pathogenesis of sepsis-induced DIC. The hallmark of DIC is thrombosis in the microvasculature; however, sepsis-induced DIC is a laboratory diagnosis based on coagulation test results and clinical setting. Although simplified criteria were recently introduced, DIC should be distinguished from other similar conditions such as thrombotic microangiopathy and heparin-induced thrombocytopenia. In DIC, treating the underlying cause is crucial, and additional adjunct therapies including antithrombin, thrombomodulin, and heparins may have potential benefit, but evidence supporting their use in terms of improvement of clinically relevant outcomes continues to be debated. In this review, we introduce recent findings regarding the pathophysiology, diagnosis, and treatment of sepsis-induced DIC. In addition, we also discuss future potential therapeutic approaches regarding this complex, life-threatening complication.
Author Levy, Jerrold H
Iba, Toshiaki
Levi, Marcel
Author_xml – sequence: 1
  givenname: Toshiaki
  surname: Iba
  fullname: Iba, Toshiaki
  organization: Department of Emergency and Disaster Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan
– sequence: 2
  givenname: Marcel
  surname: Levi
  fullname: Levi, Marcel
  organization: Department of Medicine, University College London Hospitals NHS Foundation Trust, London, United Kingdom
– sequence: 3
  givenname: Jerrold H
  surname: Levy
  fullname: Levy, Jerrold H
  organization: Department of Anesthesiology, Critical Care, and Surgery, Duke University School of Medicine, Durham, North Carolina
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31443111$$D View this record in MEDLINE/PubMed
BookMark eNpNj01LxDAYhIOsuB969Sh79BLNm6TZ5Cirq4UFD-q5vM2HVtq0Nq2w_95dXMHTDMzDMDMnk9hGT8glsBtgWXabKGPCUFBGGpOdkBkwo6lhSk7--SmZp_TJGEjN-BmZCpBSAMCMbF58l6pE8-hG691y3eL7WLcdDh-7JUa3vK9S8k0VcdineRx6_MZkxxr7I4tD1cZzchqwTv7iqAvytnl4XT_R7fNjvr7bUiuFGagr0SnQQWQmaMZ0QMVLHpRDo63DwyatMAu2DCVzxnm1B2BlMxnYCgznC3L929v17dfo01A0VbK-rjH6dkwFF0IZA6AO6NURHcvGu6Lrqwb7XfH3nf8ASE5dcw
CitedBy_id crossref_primary_10_3390_jcm11216480
crossref_primary_10_3390_ijms23095076
crossref_primary_10_7759_cureus_34103
crossref_primary_10_1186_s13054_022_04266_9
crossref_primary_10_3390_life13020350
crossref_primary_10_1016_j_yexmp_2025_104963
crossref_primary_10_1016_j_cca_2025_120558
crossref_primary_10_1111_bjh_17172
crossref_primary_10_1177_1076029620929090
crossref_primary_10_1016_j_legalmed_2023_102208
crossref_primary_10_1155_2022_8562978
crossref_primary_10_1177_1721727X251330015
crossref_primary_10_3390_jcm11041028
crossref_primary_10_3390_jcm10132860
crossref_primary_10_1186_s12959_022_00403_0
crossref_primary_10_1016_j_thromres_2022_11_028
crossref_primary_10_1055_s_0040_1716873
crossref_primary_10_1016_j_lfs_2024_122873
crossref_primary_10_1055_s_0042_1756172
crossref_primary_10_3390_ijerph18042187
crossref_primary_10_2147_OAEM_S238696
crossref_primary_10_1093_eurheartj_ehad388
crossref_primary_10_3389_fmicb_2022_947139
crossref_primary_10_1017_S1049023X20001181
crossref_primary_10_1007_s11864_023_01089_w
crossref_primary_10_1055_a_2359_2563
crossref_primary_10_1002_psp4_12574
crossref_primary_10_5582_bst_2020_03086
crossref_primary_10_1055_a_1177_5127
crossref_primary_10_3389_fmed_2021_628302
crossref_primary_10_3390_ijms25010213
crossref_primary_10_4103_jtccm_jtccm_8_21
crossref_primary_10_1007_s10753_022_01709_x
crossref_primary_10_1055_s_0043_1772572
crossref_primary_10_1097_MBC_0000000000000999
crossref_primary_10_1186_s40001_023_01301_5
crossref_primary_10_1007_s10067_020_05275_1
crossref_primary_10_2147_IJGM_S329296
crossref_primary_10_1186_s12879_022_07837_x
crossref_primary_10_1186_s12964_023_01131_2
crossref_primary_10_3390_diagnostics13132299
crossref_primary_10_1111_hdi_13046
crossref_primary_10_1177_10760296241271334
crossref_primary_10_1016_j_asjsur_2023_05_090
crossref_primary_10_3389_fimmu_2024_1500734
crossref_primary_10_3390_ijms23094596
crossref_primary_10_3390_jcm9124134
crossref_primary_10_3390_ijerph191912448
crossref_primary_10_1016_j_heliyon_2024_e33337
crossref_primary_10_1080_07853890_2025_2531252
crossref_primary_10_1177_10760296231195089
crossref_primary_10_1515_biol_2022_0659
crossref_primary_10_36290_vnl_2023_107
crossref_primary_10_1186_s40659_023_00419_4
crossref_primary_10_1186_s12906_022_03720_z
crossref_primary_10_1089_ars_2021_0056
crossref_primary_10_3390_ijms24031920
crossref_primary_10_1128_spectrum_01015_24
crossref_primary_10_1016_j_blre_2021_100864
crossref_primary_10_1097_INF_0000000000004680
crossref_primary_10_4103_jad_jad_41_24
crossref_primary_10_1016_j_hrthm_2024_12_001
crossref_primary_10_1089_jir_2022_0029
crossref_primary_10_3390_diagnostics14010042
crossref_primary_10_1111_evj_13328
crossref_primary_10_1016_j_tvir_2025_101041
crossref_primary_10_2147_JIR_S479926
crossref_primary_10_1016_j_thromres_2020_12_024
crossref_primary_10_1038_s41390_024_03717_z
crossref_primary_10_1016_j_ebiom_2022_103965
crossref_primary_10_1055_a_2651_7717
crossref_primary_10_1016_j_tcm_2021_08_012
crossref_primary_10_3389_fphar_2023_1181372
crossref_primary_10_3390_healthcare11020227
crossref_primary_10_1177_0885066620949131
crossref_primary_10_1055_s_0044_1782197
crossref_primary_10_3389_fimmu_2021_778913
crossref_primary_10_1016_j_dsx_2021_04_026
crossref_primary_10_1016_j_ccc_2021_11_010
crossref_primary_10_1038_s41590_023_01660_5
crossref_primary_10_1055_s_0040_1710337
crossref_primary_10_7717_peerj_16636
crossref_primary_10_7759_cureus_35585
crossref_primary_10_3389_fendo_2019_00944
crossref_primary_10_3390_ijms231911740
crossref_primary_10_1038_s41598_024_65738_2
crossref_primary_10_1016_j_jtcme_2023_04_001
crossref_primary_10_3390_antiox12030543
crossref_primary_10_3389_fphar_2023_1265177
crossref_primary_10_2147_IJGM_S318334
crossref_primary_10_1111_aor_14206
crossref_primary_10_3390_pathogens12070969
crossref_primary_10_3390_toxins13020160
crossref_primary_10_3390_ijms25063120
crossref_primary_10_1016_j_resplu_2023_100477
crossref_primary_10_1515_cclm_2022_0633
crossref_primary_10_1007_s11239_021_02598_x
crossref_primary_10_1016_j_rpth_2024_102463
crossref_primary_10_3390_cells12071003
crossref_primary_10_3390_jcm12175759
crossref_primary_10_2147_DDDT_S500276
crossref_primary_10_3390_jcm12093188
crossref_primary_10_1371_journal_pone_0315797
crossref_primary_10_1016_j_tcm_2020_10_011
crossref_primary_10_1186_s13063_023_07853_5
crossref_primary_10_1016_j_addr_2021_05_021
crossref_primary_10_1186_s40560_022_00596_6
crossref_primary_10_1177_10760296221077096
crossref_primary_10_1155_2022_1288535
crossref_primary_10_5847_wjem_j_1920_8642_2025_036
crossref_primary_10_3390_biomedicines10061461
crossref_primary_10_1007_s00011_025_02081_w
crossref_primary_10_58888_2957_3912_20220303
crossref_primary_10_1016_j_hbpd_2025_06_004
crossref_primary_10_25259_SNI_974_2022
crossref_primary_10_1097_MD_0000000000025255
crossref_primary_10_1021_acs_jproteome_4c00935
crossref_primary_10_1055_s_0041_1726415
crossref_primary_10_3390_ijms23094545
crossref_primary_10_1055_a_2692_3064
crossref_primary_10_1186_s40635_024_00660_5
crossref_primary_10_3390_pathogens10101239
crossref_primary_10_3390_cells11101637
crossref_primary_10_3389_fcvm_2023_1096871
ContentType Journal Article
Copyright Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
Copyright_xml – notice: Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
DBID NPM
7X8
DOI 10.1055/s-0039-1694995
DatabaseName PubMed
MEDLINE - Academic
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1098-9064
ExternalDocumentID 31443111
Genre Journal Article
GroupedDBID ---
.GJ
0R~
123
1UC
4.4
53G
5RE
5~~
AAIWL
AAKAS
AAQQT
ABJNI
ABOCM
ABZLV
ACGFO
ACGFS
ADZCM
AENEX
AEVEF
AHRAW
AHRSK
AIVKU
AJGCD
AKJTW
ALMA_UNASSIGNED_HOLDINGS
BPGNG
C45
CAG
COF
CS3
DU5
EBS
EJD
EXEOM
F5P
H13
IY8
J5H
N9A
NPM
O9-
OVD
P2P
Q3R
QTC
RIG
ROL
RTC
TEORI
TWZ
UDS
YFH
ZGI
ZXP
7X8
ACNUY
AGCGI
ID FETCH-LOGICAL-c439t-dbad618f359f8008fa62b2f6da98cda431186a5fcbfb0d9de6a6217c54f071922
IEDL.DBID 7X8
ISICitedReferencesCount 145
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000511888400012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1098-9064
IngestDate Thu Oct 02 05:24:24 EDT 2025
Thu Jan 02 22:58:41 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c439t-dbad618f359f8008fa62b2f6da98cda431186a5fcbfb0d9de6a6217c54f071922
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink https://repositorio.utp.edu.co/home
PMID 31443111
PQID 2336991162
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2336991162
pubmed_primary_31443111
PublicationCentury 2000
PublicationDate 2020-02-01
PublicationDateYYYYMMDD 2020-02-01
PublicationDate_xml – month: 02
  year: 2020
  text: 2020-02-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Seminars in thrombosis and hemostasis
PublicationTitleAlternate Semin Thromb Hemost
PublicationYear 2020
SSID ssj0014802
Score 2.6142018
SecondaryResourceType review_article
Snippet Disseminated intravascular coagulation (DIC) has been recognized as a deadly complication in sepsis, and its early recognition followed by appropriate...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 89
Title Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation
URI https://www.ncbi.nlm.nih.gov/pubmed/31443111
https://www.proquest.com/docview/2336991162
Volume 46
WOSCitedRecordID wos000511888400012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ1LSwMxEICDWhEvvh_1xQpeQ03SZDcnkWpRsKWgQm9LnlKQ3eq2gv_eyTZLT4LgJacEwmQy8yUzySB0BbwGUGsMVsJq3NWUYQl6gmH5pUivTUp0_VD4KR0Os_FYjuKFWxXTKhubWBtqW5pwR96hjAlgGSLozfQDh6pRIboaS2isohYDlAlanY6XUYRuFnMOJWxq8L3Np42cdyocXqViIsLnLPx3vKzdTH_7vxPcQVsRMJPbhUbsohVX7KGNQQyh76P-s5tWkwqHmh3G2aRXqrf5exkqE38nqrDJXYjQhwQZYNHkMdz9NtmqsW-9lgfotX__0nvAsZgCNsAcM2y1soJknnHpARIzrwTV1AurZGasAo4gmVDcG-31tZXWCehAUsO7HihEUnqI1oqycMcoUVZzaYUGzwYmgDEYTAOJGWa4Jty10WUjoRyUNUQgVOHKeZUvZdRGRwsx59PFrxo5g6MdTIKc_GH0Kdqk4dxbZ0-foZaHrerO0br5mk2qz4taC6AdjgY_oka7lA
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sepsis-Induced+Coagulopathy+and+Disseminated+Intravascular+Coagulation&rft.jtitle=Seminars+in+thrombosis+and+hemostasis&rft.au=Iba%2C+Toshiaki&rft.au=Levi%2C+Marcel&rft.au=Levy%2C+Jerrold+H&rft.date=2020-02-01&rft.issn=1098-9064&rft.eissn=1098-9064&rft.volume=46&rft.issue=1&rft.spage=89&rft_id=info:doi/10.1055%2Fs-0039-1694995&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1098-9064&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1098-9064&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1098-9064&client=summon